In consistence with our finding, IFN-γ activation of EMT has also been reported in prostate cancer (17), suggesting that EMT activation is a common mechanism underlying IFN-γ-driven metastasis in different cancers. The gene discussed is IFNG; the disease is prostate carcinoma.